...
首页> 外文期刊>Biochemistry >Modular nanotransporters of anticancer drugs conferring cell specificity and higher efficiency
【24h】

Modular nanotransporters of anticancer drugs conferring cell specificity and higher efficiency

机译:赋予细胞特异性和更高效率的抗癌药物模块化纳米转运蛋白

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This review deals with artificial modular nanotransporters (MNT) of polypeptide nature for drug delivery into target cells and then into a specified cell compartment like the nucleus. The developed approach is based on the use of intra-cellular transport processes characteristic of practically all cells, including cancer cells. The first MNT module ligand carries out a double function: specific recognition of a cancer target cell and penetration into the cell via receptor-mediated endocytosis. The movement of the MNT within the cell along this path specifies the need to supply the MNT with an endosomolytic module making it possible to leave the endocytotic pathway before getting into lysosomes in order to have time for interaction with importins. For this purpose, a polypeptide fragment able to make defects in membranes only at the pH of endosomes is used as the second module. Delivery into the cell nucleus is provided by the third module containing an amino acid sequence of nuclear localization, "recognized" by importins located in the hyaloplasm. And finally, the fourth module, a carrier for joining the transported drug, is incorporated into the MNT. Depending on the type of ligand module, MNT for different target cell types have been produced. Each module retains its activity within the MNT, ligand modules bind target receptors with high affinity, while the module with the nuclear localization sequence binds importins. The endosomolytic module forms pores in lipid membranes through which MNT are able to leave acidifying cell compartments (endosomes). Modules within MNT can be replaced or transposed, which makes it possible to use them for delivery of different drugs into different target cells and their compartments. It was shown that photosensitizers and radionuclides used for cancer therapy acquire pronounced cell specificity as well as the 10-1000-fold higher efficiency resulting from their delivery into the most vulnerable compartment--the cell nucleus. [PUBLICATION ABSTRACT]
机译:这篇综述涉及多肽性质的人工模块化纳米转运蛋白(MNT),用于将药物输送到靶细胞中,然后再输送到特定的细胞室内,如细胞核。开发的方法是基于使用几乎所有细胞(包括癌细胞)所具有的细胞内转运过程。第一个MNT模块配体具有双重功能:特异性识别癌症靶细胞并通过受体介导的内吞作用渗透进入细胞。 MNT在细胞内沿此路径的移动表明需要为MNT提供内溶酶模块,从而有可能在进入溶酶体之前离开内吞途径,以便有时间与Importins相互作用。为此目的,仅在内体的pH下能够在膜中产生缺陷的多肽片段被用作第二模块。由包含核定位的氨基酸序列的第三模块提供递送到细胞核中,所述第三模块被位于透明质体中的导入蛋白“识别”。最后,将第四模块,即用于连接所运输药物的载体,合并到MNT中。根据配体模块的类型,已生产出用于不同靶细胞类型的MNT。每个模块在MNT中保持其活性,配体模块以高亲和力结合靶受体,而具有核定位序列的模块则结合importins。内溶酶模块在脂质膜上形成孔,MNT可以通过这些孔离开酸化的细胞区室(内体)。 MNT中的模块可以更换或换位,从而可以将其用于将不同的药物输送到不同的靶细胞及其隔室中。研究表明,用于癌症治疗的光敏剂和放射性核素具有显着的细胞特异性,并且由于其传递到最易受伤害的区域-细胞核中而获得了10-1000倍的高效率。 [出版物摘要]

著录项

  • 来源
    《Biochemistry》 |2009年第13期|p.1-9|共9页
  • 作者

    A S Sobolev;

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号